GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Cash-to-Debt

MicroTech Medical (Hangzhou) Co (HKSE:02235) Cash-to-Debt : 373.56 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. MicroTech Medical (Hangzhou) Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 373.56.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, MicroTech Medical (Hangzhou) Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for MicroTech Medical (Hangzhou) Co's Cash-to-Debt or its related term are showing as below:

HKSE:02235' s Cash-to-Debt Range Over the Past 10 Years
Min: 16.47   Med: 2853.23   Max: 8441.67
Current: 373.56

During the past 5 years, MicroTech Medical (Hangzhou) Co's highest Cash to Debt Ratio was 8441.67. The lowest was 16.47. And the median was 2853.23.

HKSE:02235's Cash-to-Debt is ranked better than
91.65% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 1.99 vs HKSE:02235: 373.56

MicroTech Medical (Hangzhou) Co Cash-to-Debt Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

MicroTech Medical (Hangzhou) Co Cash-to-Debt Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
16.47 5,211.07 8,441.67 2,853.23 373.56

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash-to-Debt Get a 7-Day Free Trial 8,441.67 5,084.53 2,853.23 19,341.55 373.56

Competitive Comparison of MicroTech Medical (Hangzhou) Co's Cash-to-Debt

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroTech Medical (Hangzhou) Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Cash-to-Debt falls into.


MicroTech Medical (Hangzhou) Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

MicroTech Medical (Hangzhou) Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=2068.418 / (5.355 + 0.182)
=373.56

MicroTech Medical (Hangzhou) Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=2068.418 / (5.355 + 0.182)
=373.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroTech Medical (Hangzhou) Co  (HKSE:02235) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

MicroTech Medical (Hangzhou) Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Cash-to-Debt
Comparable Companies
HKSE:02500 HKSE:01696 HKSE:06118 HKSE:06609 HKSE:02170 HKSE:02297 HKSE:02216 HKSE:02393 HKSE:01612 HKSE:02190 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.microtechmd.com
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Zheng Pan
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p. 2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p. 2201 Interest of corporation controlled by you
Cdbi Gp, Ltd 2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p. 2201 Interest of corporation controlled by you
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines